ARTICLES IN PEER-REVIEWED JOURNALS Brustad E.M., Lelyveld V.S., Snow C.D., Crook N., Jung S.T., Martinez F.M., Scholl T.J., Jasanoff A., Arnold F.H. (2012) "Structure-guided directed evolution of highly selective P450-based magnetic resonance imaging sensors for dopamine and serotonin." J Mol Biol. 422(2):245-62. [PubMed] Hsieh V., Jasanoff A. (2012) "Bioengineered probes for molecular magnetic resonance imaging in the nervous system. ACS Chem Neurosci." 3(8):593-602. [PubMed] Lelyveld, V. S., Brustad, E., Arnold, F. H., & Jasanoff, A. (2011) "Metal-substituted protein MRI contrast agents engineered for enhanced relaxivity and ligand sensitivity," J. Am. Chem. Soc., 133(4): 649–651 [PubMed] Lee, T., Zhang, X. A., Dhar, S., Faas, H., Lippard, S. J., & Jasanoff, A. (2010) "In vivo imaging with a cell-permeable porphyrin-based MRI contrast agent," Chem. Biol. 17: 665-73. [PubMed] You, Y., Tomat, E., Hwang, K., Atanasijevic, T., Nam, W., Jasanoff, A., & Lippard, S. J. (2010) Chem. Commun. (Camb.) 46: 4139-41. [PubMed] Westmeyer, G. G., Durocher, Y., & Jasanoff, A. (2010) "A secreted enzyme reporter system for MRI," Angew. Chem. Int. Ed. Engl. 49: 1-4. [PubMed] Shapiro, M. G., Westmeyer, G. G., Romero, P. A., Szablowski, J. O., Küster, B., Shah, A., Otey, C. R., Langer, R., Arnold, F. H., & Jasanoff, A. (2010) "Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine," Nat. Biotechnol. 28: 264-70. [PubMed] Atanasijevic, T., Zhang, X. A., Lippard, S. J., & Jasanoff, A. (2010) "MRI sensing based on the displacement of paramagnetic ions from chelated complexes," Inorg. Chem. 49: 2589-91. [PubMed] Lelyveld, V. S., Atanasijevic, T., & Jasanoff, A. (2010) "Challenges for molecular neuroimaging with MRI," Int. J. Imaging Syst. Technol. 20: 71-9. [PubMed] Faas, H., Jackson, W. S., Borkowski, A. W., Wang, X., Ma, J., Lindquist, S., & Jasanoff, A. (2010) "Context-dependent perturbation of neural systems in transgenic mice expressing a cytosolic prion protein," Neuroimage 49: 2607-17. [PubMed] Jackson, W. S., Borkowski, A. W., Faas, H., Steele, A. D., King, O. D., Watson, N., Jasanoff, A., & Lindquist, S. (2009) "Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice," Neuron 63: 438-50. [PubMed] Shapiro, M. G., Szablowski, J. O., Langer, R., & Jasanoff, A. (2009) "Protein nanoparticles engineered to sense kinase activity in MRI," J. Am. Chem. Soc. 131: 2484-6. [PubMed] Matsumoto, Y., & Jasanoff, A. (2008) “T2 relaxation induced by clusters of superparamagnetic nanopar-ticles: Monte Carlo simulations,” Magn. Reson. Imaging 26: 994-8. [PubMed] Colonnese, M. T., Phillips, M. A., Constantine-Paton, M., Kaila, K., & Jasanoff, A. (2008) Nat. Neurosci. 11: 72-9. [PubMed] Jasanoff, A. (2007) "MRI contrast agents for functional molecular imaging of brain activity," Curr. Opin. Neurobiol. 17: 593-600. [PubMed] Atanasijevic, T. & Jasanoff, A. (2007) "Preparation of iron oxide-based calcium sensors for MRI," Nat. Protoc. 2: 2582-9. [PubMed] Jasanoff, A. (2007) "Bloodless fMRI," Trends Neurosci. 30: 603-10. [PubMed] Zhang, X. A., Lovejoy, K. S., Jasanoff, A., & Lippard, S. J. (2007) "Water-soluble porphyrins as dual-function molecular imaging platform for MRI and fluorescence zinc sensing," Proc. Natl. Acad. Sci. USA 104: 10780-5. [PubMed] Westmeyer, G. G. & Jasanoff, A. (2007) "Genetically controlled MRI contrast mechanisms and their prospects in systems neuroscience research," Magn. Reson. Imaging 25: 1004-10. [PubMed] Green, D. F., Dennis, A. T., Fam, P. S., Tidor, B., & Jasanoff, A. (2006) "Rational design of new binding specificity by simultaneous mutagenesis of calmodulin and a target peptide," Biochemistry 45: 12547-59. [PubMed] Atanasijevic, T., Shusteff, M., Fam, P., & Jasanoff, A. (2006) "Calcium-sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulin," Proc. Natl. Acad. Sci. USA 103: 14707-12. [PubMed] Shapiro, M. G., Atanasijevic, T., Faas, H., Westmeyer, G. G., & Jasanoff, A. (2006) "Dynamic imaging with MRI contrast agents: quantitative considerations." Magn. Reson. Imaging 24: 449-62. [PubMed] Kim, S. W., Kim, S., Tracy, J. B., Jasanoff, A., & Bawendi, M. G. (2005) "Phosphine oxide polymer for water-soluble nanoparticles," J. Am. Chem. Soc. 127: 4556-7. [PubMed] Jasanoff, A. (2005) “Functional MRI Using Molecular Imaging Agents,” Trends Neurosci. 28: 120-6. [PubMed] Sun, P.Z. & Jasanoff, A. (2003) “In Vivo Oxygen Detection Using Exogenous Hemoglobin as a Contrast Agent in Magnetic Resonance Microscopy,” Magn. Reson. Med. 49: 609-14. [PubMed] Jasanoff, A. & Sun, P. Z. (2002) "In Vivo Magnetic Resonance Microscopy of Brain Structure in Unanesthetized Flies," J. Magn. Reson. 158: 79-85. [PubMed] Walters, K. J., Ferentz, A. E., Hare, B. J., Hidalgo, P., Jasanoff, A., Matsuo, H., & Wagner, G. (2001) “Characterizing Protein-Protein Complexes and Oligomers by Nuclear Magnetic Resonance Spectroscopy,” Methods Enzymol. 339: 238-58. Jasanoff, A., Song, S., Dinner, A. R., Wagner, G., & Wiley, D. C. (1999) “One of Two Unstructured Domains of Ii Becomes Ordered in Complexes with MHC Class II Molecules,” Immunity 10: 761-768. [PubMed] Jasanoff, A., Wagner, G., & Wiley, D. C. (1998) “Structure of a Trimeric Functional Domain of the MHC Class II-Associated Invariant Chain,” EMBO J. 17: 6812-6818. [PubMed] Jasanoff, A. (1998) “An Asymmetric Deuterium Labeling Strategy to Identify Interprotomer and Intraprotomer NOEs in Oligomeric Proteins,” J. Biomol. NMR 12: 299- 306. [PubMed] Pugmire, M. J., Cook, W. J., Jasanoff, A., Walter, M. R., & Ealick, S. E. (1998)“Structural and Theoretical Studies Suggest Domain Movement Produces an Active Conformation of Thymidine Phosphorylase,” J. Mol. Biol. 281: 285-299. [PubMed] Jasanoff, A., Park, S.-J., & Wiley, D. C. (1995) “Direct Observation of Disordered Regions in the MHC class II-Associated Invariant Chain,” Proc. Natl. Acad. Sci. USA 92: 9900-9904. [PubMed] Jasanoff, A., Davis, B. J., & Fersht, A. R. (1994) "Detection of an Intermediate in the Folding of the (ab)8-barrel (Phosphoribosyl)anthranilate Isomerase from Escherichia coli," Biochemistry 33: 6350-6355. [PubMed] Jasanoff, A. & Fersht, A. R. (1994) “Quantitative Determination of Helical Propensities from TFE Titration Curves,” Biochemistry 33: 2129-2135. [PubMed] FULL LISTING IN PUBMED OTHER PUBLICATIONS Jasanoff, A. (2008) "Contrast Agents for Magnetic Resonance Imaging: An Overview," in Cancer Imaging, vol. 1, Hayat, M. A., ed., Elsevier (New York). Jasanoff, A. (2006) "New technology for bioimaging with MRI," Asia Pacific Biotech. News 10(6). [Link] Jasanoff, A. (2005) "Shadowing consciousness and tracking molecules with magnetic resonance imaging," BioForum Europe 5: 49-51. [Link]